vaccin gripal trivalent purificat si inactivat
inc cantacuzino - vaccin gripal inactivat - susp. inj. - vaccinuri virale vaccinuri gripale
ornipest, vaccin
biovet, cehia - vaccin - vaccin viu liofilizat - păsări domestice
rabivac –o/333, vaccin
pokrovskiy zavod biopreparatov srl, rusia - vaccina - vaccin viu lichid,momeală - fauna sălbatică
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccinuri - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.
engerix b 10 µg/0,5 ml
glaxosmithkline biologicals s.a. - belgia - vaccin hepatitic b - susp. inj. - 10µg/0,5ml - vaccinuri virale vaccinuri hepatitice
stamaril, vaccin pentru febra galbena, atenuat
sanofi pasteur - franta - vaccin viu atenuat impotriva febrei galbene - pulb.+solv. pt. susp. inj. in seringa preumpluta - vaccinuri virale vaccin pentru febra galbena
vaccină antirabică inactivată formă lichidă (vniiyj)
fgbu ''vniizj'', or.vladimir, rusia - vaccină - vaccin inactivat
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaccinuri - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
rotateq vaccin rotavirus viu pentavalent 1 doză soluţie orală
merck sharp & dohme idea gmbh - vaccin rotavirus, viu, pentavalentă - soluţie orală - 1 doză